Andorra vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, HepB3

Andorra
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
83.7%
in 2024
Andorra rank
26th
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
27th

Immunization, HepB3 over time

  • Andorra
  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
020406080100198520042024

How they compare

Andorra currently reports 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 13.3%.

That makes Andorra's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 28 years both countries report, Andorra has been ahead every year.

Andorra ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th of 188 countries.

Andorra has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Andorra Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Difference Ahead
1990s 76.7% 31.1% 45.6% Andorra
2000s 85.7% 61.6% 24.1% Andorra
2010s 96.3% 79.5% 16.8% Andorra
2020s 97.2% 82.6% 14.6% Andorra

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hepb3, Andorra or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
Andorra, at 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
What is the difference in immunization, hepb3 between Andorra and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
13.3%, with Andorra ahead.
How many years of comparable data are there for Andorra and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
28 years are reported by both, from 1997 to 2024.
How do Andorra and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for immunization, hepb3?
Andorra ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th of 188 countries.
Where does this data come from?
World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Andorra vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, HepB3. Statizoid, drawing on World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/immunization-hepb3-percent-of-one-year-old-children/andorra/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hepb3-percent-of-one-year-old-children/andorra/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/">Andorra vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, HepB3</a> — Statizoid

About this data

Indicator
Immunization, HepB3 (% of one-year-old children)
Unit
% of one-year-old children
Source
World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 6,534 data points, 1985–2024
Last refreshed

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.